Autoimmune Disease clinical trials
38 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Testicular Tissue Cryopreservation for Fertility Preservation
- Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
- Secukinumab Open Label Roll-over Extension Protocol
- Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
- A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
- Atacicept in Multiple Glomerular Diseases
- A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Ovarian Tissue Cryopreservation for Fertility Preservation
- Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
- Autoimmune and Autoinflammatory Genetics Study
- Novel Genetic Disorders of the Immune System
- Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
- The Mycophenolate Pregnancy Registry
- Detection and Characterization of Infections and Infection Susceptibility
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
- Deciphering the Genetic Architecture of Autoimmune Diseases
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
- IMPACT - AndHealth Autoimmune Research Registry
- Allergy and Immunology Natural History Study
- Interstitial Lung Disease Research Unit Biobank
- Biologics And Clinical Immunology Cohort at Sinai
- Collection and Distribution of Biospecimens for Novel Research Uses
- Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
- Natural History of Bronchiectasis
- Immune System Related Kidney Disease
- Testimonials and Navigation in Rheumatology
- Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder
- Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans
- Health-Related Social Needs Food Boxes Delivery Program
- Network to Understand Reproductive Rheumatology Registry
- Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
- AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
- Comparative Autoantibody and Immunologic Cell Marker Study
- A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Autoimmune Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.